C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease

C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is characterised by accelerated lipid deposition, aberrant inflammation, and excessive extracellular matrix production in the liver. Short of effective intervention, NAFLD can progress to cirrhosis and hepatocellular carcinoma. In...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Zhiwen Fan, Xinyue Sun, Xuelian Chen, Huimin Liu, Xiulian Miao, Yan Guo, Yong Xu, Jie Li, Xiaoping Zou, Zilong Li
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Elsevier 2023-09-01
Sraith:JHEP Reports
Ábhair:
Non-alcoholic fatty liver disease
Hepatocytes
Transcriptional regulation
Chemokine
Inflammation
Rochtain ar líne:http://www.sciencedirect.com/science/article/pii/S2589555923001362

Ar líne

http://www.sciencedirect.com/science/article/pii/S2589555923001362

Míreanna comhchosúla